Organization Overview
Alternative names
aldesleukin (Proleukin) (1 trial)
brigatinib (alunbrig) (1 trial)
cabozantinib (cometriq) (2 trials)
fedratinib (Inrebic) (1 trial)
glofitamab (Columvi) (1 trial)
lenvatinib (lenvima) (2 trials)
Adenocarcinoma (Phase 3)
Biliary Tract Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Fibrosis (Phase 2)
Liver Cirrhosis (Phase 2)
Lung Neoplasms (Phase 2)
Rectal Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 2)